Acid-Base Homeostasis During Vasopressin V2 Receptor Antagonist Treatment in Autosomal Dominant Polycystic Kidney Disease Patients

Podobne zapisy

• Dose-Titrated Vasopressin V2 Receptor Antagonist Improves Renoprotection in a Mouse Model for Autosomal Dominant Polycystic Kidney Disease
  od: Zittema, Debbie, i wsp.
  Wydane: (2016)
• Somatostatin in renal physiology and autosomal dominant polycystic kidney disease
  od: Messchendorp, A Lianne, i wsp.
  Wydane: (2019)
• Copeptin, a Surrogate Marker of Vasopressin, Is Associated with Disease Severity in Autosomal Dominant Polycystic Kidney Disease
  od: Meijer, Esther, i wsp.
  Wydane: (2011)
• Early Renal Abnormalities in Autosomal Dominant Polycystic Kidney Disease
  od: Meijer, Esther, i wsp.
  Wydane: (2010)
• Author’s Reply to Correspondence: “Effect of Tolvaptan Treatment on Acid−Base Homeostasis in ADPKD Patients”
  od: Heida, Judith E., i wsp.
  Wydane: (2021)